Drug group acquisition boosts BTG
A full half-year of contributions from Protherics boost revenues at the biotechnology group as it looks forward to the direct marketing of two major drugs in the US next year
source : traxfer.ft.com
How DUMB are YOU?!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Home Income Profit System
You can make money working from the comfort of your own home!
CreditReport.com
Get your credit report and score in just seconds!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
Do your friends think you are stupid? Take the challenge and prove them wrong!
Get 5 Books for 99 cents!
The most popular books at the most popular prices!
Home Income Profit System
You can make money working from the comfort of your own home!
CreditReport.com
Get your credit report and score in just seconds!
Beat your friends on IQ Challenge!
Take the 10-Minute IQ Challenge today. Prove to your friends that you aren't stupid after all!
Related News:
- Acne Drug Prevents HIV Breakout
- Increasing Understanding Of Drug Metabolism Provides Key Knowledge About Drug Toxicity And Effectiveness
- SGO: Drug Combination Slows Recurrent Ovarian Cancer
- PEGylated dendrimers: A novel mechanism of drug delivery
- New Drug Candidate Reduces Blood Lipids
- Agency For Healthcare Research And Quality News And Numbers: High Cholesterol, Diabetes Lead Drug Spending For The Elderly
- Grandfathered Drug For High Potassium Has No Proven Benefit
- Medicare to Drug Plan Operator: You’re Fired
- Hot road to new drugs: Efficient identification of drug candidates
- Advanced Cell Technology’s RPE Cells Granted Orphan Drug Status From FDA For Treatment Of Stargardt’s Macular Dystrophy
Details :
Submited at Friday, November 6th, 2009 at 1:00 am on Pharmaceutical by madison
Comment RSS 2.0 - leave a comment - trackback
Leave Comment Here...